Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants

2009100 citationsJournal Article

Authors

Tessa Goetghebuer · Centre Hospitalier Universitaire de Saint-Pierre

Edwige Haelterman · Centre Hospitalier Universitaire de Saint-Pierre

Jérôme Le Chenadec · Inserm

Catherine Dollfus · Assistance Publique – Hôpitaux de Paris

Diana M. Gibb · MRC Clinical Trials Unit at UCL

Ali Judd · MRC Clinical Trials Unit at UCL

Hannah Green

Abstract

In HIV-1 vertically infected infants, starting antiretroviral therapy before the age of 3 months is associated with a significant reduction in progression to AIDS and death.

Topics & Keywords

HIV/AIDS Research and Interventions HIV Research and Treatment HIV-related health complications and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: AIDS

Volume 23, Issue 5, pp. 597-604

DOI: 10.1097/qad.0b013e328326ca37

Field-Weighted Citation Impact: 6.99